Now showing items 1-7 of 7

    • Acoustics-induced Fluid Motions 

      Chen, Chuyi (2021)
      Acoustic waves, as a form of mechanical vibration, not only induces the force directly on the object, but also induces the motion of the medium that propagates throughout the system. The study of acoustofluidic mainly focuses ...
    • Architectures of Aliveness: Building Beyond Gravity 

      Boucher, Marie-Pier (2015)
      In the context of today's global mobility, information, bodies and goods are circulating across the globe, and even further into outer space. However, we face a paradox: the more we move, the more we become sedentary. The ...
    • Bioorthogonal Functionalization of Elastin-like Polypeptides 

      Costa, Simone (2019)
      Recombinant technology has given us the powerful ability to imagine and create novel biological entities, from potent therapeutics to functionally active materials. By harnessing nature’s building blocks and reconfiguring ...
    • Modular nanotransporters: a multipurpose in vivo working platform for targeted drug delivery. 

      Slastnikova, Tatiana A; Rosenkranz, Andrey A; Gulak, Pavel V; Schiffelers, Raymond M; Lupanova, Tatiana N; Khramtsov, Yuri V; Zalutsky, Michael R; ... (8 authors) (Int J Nanomedicine, 2012)
      BACKGROUND: Modular nanotransporters (MNT) are recombinant multifunctional polypeptides created to exploit a cascade of cellular processes, initiated with membrane receptor recognition to deliver selective short-range and ...
    • Regulatory and cost barriers are likely to limit biosimilar development and expected savings in the near future. 

      Grabowski, Henry G; Guha, Rahul; Salgado, Maria (Health Aff (Millwood), 2014-06)
      In March 2010 Congress established an abbreviated Food and Drug Administration approval pathway for biosimilars-drugs that are very similar but not identical to a reference biological product and cost less. Because bringing ...
    • The quantity and quality of worldwide new drug introductions, 1982-2003. 

      Grabowski, Henry G; Wang, Y Richard (Health Aff (Millwood), 2006-03)
      We examined trends in the introduction of new chemical entities (NCEs) worldwide from 1982 through 2003. Although annual introductions of NCEs decreased over time, introductions of high-quality NCEs (that is, global and ...
    • The roles of patents and research and development incentives in biopharmaceutical innovation. 

      Grabowski, Henry G; DiMasi, Joseph A; Long, Genia (Health Aff (Millwood), 2015-02)
      Patents and other forms of intellectual property protection play essential roles in encouraging innovation in biopharmaceuticals. As part of the "21st Century Cures" initiative, Congress is reviewing the policy mechanisms ...